Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL
Clinical trial NCT03740334 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03740334
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-30
- Primary completion
- 2023-03-04
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.